Here are three healthcare stocks that are too cheap to ignore (listed in alphabetical order). The company's enterprise value (EV) is only 6.28 times its earnings before interest, taxes, depreciation, and amortization (EBITDA). It's no secret why Pfizer stock is relatively cheap.
Combining the actual results with the estimates for the still-to-report companies, total earnings for the healthcare sector are expected to decline 9% on revenue growth of 4.3%.
Deciphera (DCPH) reports a wider-than-expected loss per share for the fourth quarter of 2022, while revenues driven by Qinlock sales, beat estimates.